Non small cell lung cancer other imaging findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Trushatank (talk | contribs) No edit summary |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Other imaging findings of non-small cell lung cancer include [[PET scan|PET]] | Other imaging findings of non-small cell lung cancer include [[PET scan|PET]] and [[pulmonary angiography]]. | ||
==Other Imaging Findings== | ==Other Imaging Findings== | ||
===PET | ===PET=== | ||
[[PET]] | [[Positron emission tomography|PET scanning]] with the tracer fluorine-18 (F-18) [[fluorodeoxyglucose|fluorodeoxyglucose (FDG)]], called [[Positron emission tomography|FDG-PET]], is widely used in the diagnosis of non-small cell lung cancer, for the following reasons:<ref name="pmid16014441">{{cite journal |vauthors=Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, Choi JY, Kwon OJ, Shim YM, Kim S |title=Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging |journal=Radiology |volume=236 |issue=3 |pages=1011–9 |year=2005 |pmid=16014441 |doi=10.1148/radiol.2363041310 |url=}}</ref><ref name="pmid21331927">{{cite journal |vauthors=Steinert HC |title=PET and PET-CT of lung cancer |journal=Methods Mol. Biol. |volume=727 |issue= |pages=33–51 |year=2011 |pmid=21331927 |doi=10.1007/978-1-61779-062-1_3 |url=}}</ref> | ||
* General follow-up | |||
*Characterization of treatment response | |||
*Staging modality (in the risk of missing occult disease) | |||
*Findings associated with non-small cell lung cancer on PET/CT include: | *Findings associated with non-small cell lung cancer on PET/CT include: | ||
**The CT scan demonstrates abnormalities such as a [[Pulmonary nodule|lung nodule]] or [[enlarged lymph nodes]]. Whereas, the PET scan reveals increased metabolism in structures which contain rapidly growing cancer cells | |||
**Intense radiolabeling of tissues with high glucose uptake, such as the brain, the liver, and malignant tumor cells. | |||
===Pulmonary Angiography=== | ===Pulmonary Angiography=== | ||
*On [[pulmonary angiography]], findings of non-small cell lung cancer, include:<ref name="pmid5483666">{{cite journal |vauthors=Delarue NC, Sanders DE, Silverberg SA |title=Complementary value of pulmonary angiography and mediastinoscopy in individualizing treatment for patients with lung cancer |journal=Cancer |volume=26 |issue=6 |pages=1370–8 |year=1970 |pmid=5483666 |doi= |url=}}</ref> | *On [[pulmonary angiography]], findings of non-small cell lung cancer, include:<ref name="pmid5483666">{{cite journal |vauthors=Delarue NC, Sanders DE, Silverberg SA |title=Complementary value of pulmonary angiography and mediastinoscopy in individualizing treatment for patients with lung cancer |journal=Cancer |volume=26 |issue=6 |pages=1370–8 |year=1970 |pmid=5483666 |doi= |url=}}</ref> | ||
**Evaluation of central [[pulmonary artery]] invasion | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 19:30, 9 January 2019
|
Non Small Cell Lung Cancer Microchapters |
|
Differentiating Non Small Cell Lung Cancer from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Non small cell lung cancer other imaging findings On the Web |
|
American Roentgen Ray Society Images of Non small cell lung cancer other imaging findings |
|
Non small cell lung cancer other imaging findings in the news |
|
Directions to Hospitals Treating Non small cell carcinoma of the lung |
|
Risk calculators and risk factors for Non small cell lung cancer other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
Other imaging findings of non-small cell lung cancer include PET and pulmonary angiography.
Other Imaging Findings
PET
PET scanning with the tracer fluorine-18 (F-18) fluorodeoxyglucose (FDG), called FDG-PET, is widely used in the diagnosis of non-small cell lung cancer, for the following reasons:[1][2]
- General follow-up
- Characterization of treatment response
- Staging modality (in the risk of missing occult disease)
- Findings associated with non-small cell lung cancer on PET/CT include:
- The CT scan demonstrates abnormalities such as a lung nodule or enlarged lymph nodes. Whereas, the PET scan reveals increased metabolism in structures which contain rapidly growing cancer cells
- Intense radiolabeling of tissues with high glucose uptake, such as the brain, the liver, and malignant tumor cells.
Pulmonary Angiography
- On pulmonary angiography, findings of non-small cell lung cancer, include:[3]
- Evaluation of central pulmonary artery invasion
References
- ↑ Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, Choi JY, Kwon OJ, Shim YM, Kim S (2005). "Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging". Radiology. 236 (3): 1011–9. doi:10.1148/radiol.2363041310. PMID 16014441.
- ↑ Steinert HC (2011). "PET and PET-CT of lung cancer". Methods Mol. Biol. 727: 33–51. doi:10.1007/978-1-61779-062-1_3. PMID 21331927.
- ↑ Delarue NC, Sanders DE, Silverberg SA (1970). "Complementary value of pulmonary angiography and mediastinoscopy in individualizing treatment for patients with lung cancer". Cancer. 26 (6): 1370–8. PMID 5483666.